Patent Assignment
Reel/Frame 066793/0513
Merger
Recorded: 2024-03-11
Pages: 3
Assignor
INHIBRX, LP
Executed: 2018-04-30
Assignee
INHIBRX, INC.
11099 NORTH TORREY PINES ROAD, SUITE 280, LA JOLLA, CALIFORNIA, 92037
Covered Property
(1)
Non-Platelet Depleting and Non-Red Blood Cell Depleting CD47 Antibodies and Methods of Use Thereof
Application:
18/451,025 →
Publication:
US 2024/0166744
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 11, 2024
From: ECKELMAN, BRENDAN; TIMMER, JOHN; RAZAI, AMIR; DEVERAUX, QUINN
To: INHIBRX, LLC
Reel/Frame 066719/0191 →
Change of Name
Mar 11, 2024
From: INHIBRX, LLC
To: INHIBRX, LP
Reel/Frame 066793/0473 →
Assignment of Assignor's Interest
Jun 10, 2024
From: INHIBRX, INC.
To: INHIBRX BIOSCIENCES, INC.
Reel/Frame 067680/0770 →
Security Interest
Jan 14, 2025
From: INHIBRX BIOSCIENCES, INC.
To: OXFORD FINANCE LLC; OXFORD FINANCE LLC
Reel/Frame 069894/0045 →